
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States.
Clinical Pearl of the Day: Breast Cancer
Breast cancer is a cancer that forms in the cells of the breasts.
Insight:
Sources:






